In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria

被引:27
作者
Nord, CE
机构
关键词
D O I
10.1093/clinids/23.Supplement_1.S15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The in vitro activities of ciprofloxacin, lomefloxacin, ofloxacin, sparfloxacin, and DU-6859a against peptostreptococci, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, Porphyromonas, Prevotella, and Fusobacterium were determined by an agar dilution method. These activities were compared with those of piperacillin/tazobactam, cefoxitin, imipenem, clindamycin, and metronidazole. Imipenem, metronidazole, and DU-6859a were the most active antimicrobial agents that were tested. The in vitro activity of DU-6859a was superior to those of ciprofloxacin, lomefloxacin, ofloxacin, and sparfloxacin.
引用
收藏
页码:S15 / S18
页数:4
相关论文
共 15 条
[1]  
CARBON C, 1995, DRUGS S2, V49, P1
[2]   ANAEROBIC INFECTIONS IN HUMANS - AN OVERVIEW [J].
FINEGOLD, SM .
ANAEROBE, 1995, 1 (01) :3-9
[3]   COMPARATIVE ACTIVITY OF CIPROFLOXACIN, OFLOXACIN, SPARFLOXACIN, TEMAFLOXACIN, CI-960, CI-990, AND WIN-57273 AGAINST ANAEROBIC-BACTERIA [J].
GOLDSTEIN, EJC ;
CITRON, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1158-1162
[4]   PATTERNS OF SUSCEPTIBILITY TO FLUOROQUINOLONES AMONG ANAEROBIC BACTERIAL ISOLATES IN THE UNITED-STATES [J].
GOLDSTEIN, EJC .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S377-S381
[5]  
GOOTZ TD, 1994, DIAGN MICR INFEC DIS, V19, P235
[6]   IN-VITRO ACTIVITY OF DU-6859A, A NEW FLUOROCYCLOPROPYL QUINOLONE [J].
MARSHALL, SA ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2747-2753
[7]  
Murray PR., 1995, MANUAL CLIN MICROBIO
[8]   IN-VITRO ANTIBACTERIAL ACTIVITY OF DU-6859A, A NEW FLUOROQUINOLONE [J].
NAKANE, T ;
IYOBE, S ;
SATO, K ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2822-2826
[9]  
*NAT COMM CLIN LAB, 1993, M11A3 NAT COMM CLIN
[10]   IN-VITRO ACTIVITY OF THE NEW FLUOROQUINOLONE CP-99,219 [J].
NEU, HC ;
CHIN, NX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2615-2622